3,6,9,12,17-pentazapentacyclo[12.8.0.03,7.08,12.016,21]docosa-1(14),4,6,8,10,15,17,19,21-nonaene;1-propyl-2-[1-(3,3,3-trifluoropropyl)imidazol-2-yl]imidazole;3,6,9,12-tetrazatetracyclo[12.4.0.03,7.08,12]octadeca-1(18),4,6,8,10,14,16-heptaene
C43H40F3N13 — CID 159699206
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3,6,9,12,17-pentazapentacyclo[12.8.0.03,7.08,12.016,21]docosa-1(14),4,6,8,10,15,17,19,21-nonaene;1-propyl-2-[1-(3,3,3-trifluoropropyl)imidazol-2-yl]imidazole;3,6,9,12-tetrazatetracyclo[12.4.0.03,7.08,12]octadeca-1(18),4,6,8,10,14,16-heptaene
3,6,9,12,17-pentazapentacyclo[12.8.0.03,7.08,12.016,21]docosa-1(14),4,6,8,10,15,17,19,21-nonaene;1-propyl-2-[1-(3,3,3-trifluoropropyl)imidazol-2-yl]imidazole;3,6,9,12-tetrazatetracyclo[12.4.0.03,7.08,12]octadeca-1(18),4,6,8,10,14,16-heptaene (PubChem CID 159699206) has the molecular formula C43H40F3N13 and a molecular weight of 795.88 g/mol. Its IUPAC name is 3,6,9,12,17-pentazapentacyclo[12.8.0.03,7.08,12.016,21]docosa-1(14),4,6,8,10,15,17,19,21-nonaene;1-propyl-2-[1-(3,3,3-trifluoropropyl)imidazol-2-yl]imidazole;3,6,9,12-tetrazatetracyclo[12.4.0.03,7.08,12]octadeca-1(18),4,6,8,10,14,16-heptaene.
Molecular Properties
| Compound Name | 3,6,9,12,17-pentazapentacyclo[12.8.0.03,7.08,12.016,21]docosa-1(14),4,6,8,10,15,17,19,21-nonaene;1-propyl-2-[1-(3,3,3-trifluoropropyl)imidazol-2-yl]imidazole;3,6,9,12-tetrazatetracyclo[12.4.0.03,7.08,12]octadeca-1(18),4,6,8,10,14,16-heptaene |
|---|---|
| PubChem CID | 159699206 |
| Molecular Formula | C43H40F3N13 |
| Molecular Weight | 795.88 g/mol |
| Exact Mass | 795.35 |
| IUPAC Name | 3,6,9,12,17-pentazapentacyclo[12.8.0.03,7.08,12.016,21]docosa-1(14),4,6,8,10,15,17,19,21-nonaene;1-propyl-2-[1-(3,3,3-trifluoropropyl)imidazol-2-yl]imidazole;3,6,9,12-tetrazatetracyclo[12.4.0.03,7.08,12]octadeca-1(18),4,6,8,10,14,16-heptaene |
| SMILES | CCCn1ccnc1-c1nccn1CCC(F)(F)F.c1ccc2c(c1)Cn1ccnc1-c1nccn1C2.c1cnc2cc3c(cc2c1)Cn1ccnc1-c1nccn1C3 |
| InChI | InChI=1S/C17H13N5.C14H12N4.C12H15F3N4/c1-2-12-8-13-10-21-6-4-19-16(21)17-20-5-7-22(17)11-14(13)9-15(12)18-3-1;1-2-4-12-10-18-8-6-16-14(18)13-15-5-7-17(13)9-11(12)3-1;1-2-6-18-8-4-16-10(18)11-17-5-9-19(11)7-3-12(13,14)15/h1-9H,10-11H2;1-8H,9-10H2;4-5,8-9H,2-3,6-7H2,1H3 |
| InChIKey | MXKFRHQZAQINCY-UHFFFAOYSA-N |
| XLogP | 7.97 |
| TPSA | 119.81 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 795.88 |
| LogP ≤ 5 | 7.97 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159699206 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.